arrow
S

Suthat Liangpunsakul

indiana university system
H指数:63
被引数:1.3万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Homeobox a4 is proapoptotic in the AC16 human cardiomyocyte cell line and a key effector of the MIAT/miR-150 axis in murine myocardial infarction

同源盒A4在AC16人心肌细胞系中具有促凋亡作用,并是小鼠心肌梗死中MIAT/miR-150轴的关键效应因子

2026-09-140
OA
IL15-mediated crosstalk between LSECs and CD8+ tissue-resident memory T cells drives alcohol-associated hepatitis

IL15介导的LSECs与CD8+组织驻留记忆T细胞之间的串扰驱动酒精性肝炎

2026-07-010
PRE
BACH2 links β1-adrenergic receptor/β-arrestin1 signaling to MIAT to inhibit cardiac fibroblast activation and cardiomyocyte apoptosis

BACH2将β1-肾上腺素能受体/β-arrestin1信号通路与MIAT联系起来,以抑制成纤维细胞活化和心肌细胞凋亡。

2026-02-280
OAAI
Improved survival and reduced alcohol-associated hepatitis risk with renin-angiotensin-aldosterone system inhibitors in alcohol-associated liver disease

在酒精性肝病中,使用肾素-血管紧张素-醛固酮系统抑制剂可改善生存率并降低酒精性肝炎风险。

2026-02-250
PRE
Identification of a common ketohexokinase-dependent link driving alcohol intake and alcohol-associated liver disease in mice

鉴定一种共同的依赖果糖激酶的关联,驱动小鼠酒精摄入和酒精性肝病

2025-11-100
OAAI
Effect of varenicline on major adverse liver outcomes in alcohol-associated liver disease: An exploratory analysis

酒精致肝病患者中伐尼克兰对主要不良肝脏结局的影响:一项探索性分析

2025-09-010
OAAI
Human PXR Signaling Exacerbates Ethanol-Induced Liver Injury in Females: Evidence from Mouse Models and Human ALD Cohorts

人PXR信号加剧乙醇诱导的雌性肝损伤:来自小鼠模型和人类ALD队列的证据

2025-07-160
OAAI
Comparative Efficacy and Safety of First-Line Treatment with Atezolizumab/Bevacizumab vs. Tyrosine-kinase inhibitors in Patients with Unresectable Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis

比较阿替利珠单抗/贝伐珠单抗一线治疗与酪氨酸激酶抑制剂在不可切除肝细胞癌患者中的疗效和安全性:一项系统评价和荟萃分析

2025-07-070
PRE
Stressed hepatocyte sustains alcohol-associated hepatitis progression by producing leukocyte cell-derived chemotaxin 2

应激肝细胞通过产生白细胞细胞衍生趋化因子2维持酒精性肝炎的进展

GUT
IF25.8
2025-03-262
PRE